PT923581E - Beta-carbolina 4-substituidas como imunomoduladores. - Google Patents

Beta-carbolina 4-substituidas como imunomoduladores.

Info

Publication number
PT923581E
PT923581E PT97938122T PT97938122T PT923581E PT 923581 E PT923581 E PT 923581E PT 97938122 T PT97938122 T PT 97938122T PT 97938122 T PT97938122 T PT 97938122T PT 923581 E PT923581 E PT 923581E
Authority
PT
Portugal
Prior art keywords
carboline
immunomodulators
beta
substituted
Prior art date
Application number
PT97938122T
Other languages
English (en)
Portuguese (pt)
Inventor
Karl D Hargrave
Clara K Miao
Thomas P Parks
Ian F Potocki
Roger J Snow
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of PT923581E publication Critical patent/PT923581E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PT97938122T 1996-08-09 1997-08-08 Beta-carbolina 4-substituidas como imunomoduladores. PT923581E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2365096P 1996-08-09 1996-08-09

Publications (1)

Publication Number Publication Date
PT923581E true PT923581E (pt) 2003-10-31

Family

ID=21816410

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97938122T PT923581E (pt) 1996-08-09 1997-08-08 Beta-carbolina 4-substituidas como imunomoduladores.

Country Status (10)

Country Link
US (1) US6093723A (enExample)
EP (1) EP0923581B1 (enExample)
JP (1) JP2000516231A (enExample)
AT (1) ATE240955T1 (enExample)
CA (1) CA2262796C (enExample)
DE (1) DE69722220T2 (enExample)
DK (1) DK0923581T3 (enExample)
ES (1) ES2194213T3 (enExample)
PT (1) PT923581E (enExample)
WO (1) WO1998006719A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001047510A2 (en) * 1999-12-29 2001-07-05 Glaxo Group Limited Methods and compositions related to modulators of annexin and cartilage homeostasis
EP1134221A1 (en) * 2000-03-15 2001-09-19 Aventis Pharma Deutschland GmbH Substituted beta-carbolines as lkB kinase inhibitors
CA2402549A1 (en) * 2000-03-15 2001-09-20 Aventis Pharma Deutschland Gmbh Substituted beta-carbolines
US6379900B1 (en) 2000-05-09 2002-04-30 Conceptual Mindworks, Inc. Compositions and methods of use of 8-nitroguanine
US20030045541A1 (en) * 2001-07-23 2003-03-06 Christopher Bruckner GABA-Receptor modulators with NMDA-Antagonistic activity
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
US8119655B2 (en) * 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
JP2012051804A (ja) * 2008-12-26 2012-03-15 Kyoto Univ Ｅｇ５阻害剤
JP5320083B2 (ja) * 2009-01-13 2013-10-23 坂元醸造株式会社 潰瘍性大腸炎治療薬
WO2010138644A1 (en) * 2009-05-27 2010-12-02 Ptc Therapeutics, Inc. Processes for the preparation of substituted tetrahydro beta-carbolines
WO2010138652A1 (en) 2009-05-27 2010-12-02 Ptc Therapeutics, Inc. Methods for treating kaposi sarcoma
WO2010138685A1 (en) 2009-05-27 2010-12-02 Ptc Therapeutics, Inc. Methods for treating prostate conditions
HUE052510T2 (hu) 2009-05-27 2021-05-28 Ptc Therapeutics Inc Módszerek a rák és a nem daganatos állapotok kezelésére
EP2563759B1 (en) 2010-04-27 2022-04-06 Calcimedica, Inc. Compounds that modulate intracellular calcium
JP6112486B2 (ja) 2010-04-27 2017-04-12 カルシメディカ，インク． 細胞内カルシウムを調節する化合物
US10703722B2 (en) 2010-04-27 2020-07-07 Calcimedica, Inc. Compounds that modulate intracellular calcium
CN103180316A (zh) 2010-08-27 2013-06-26 钙医学公司 调节细胞内钙的化合物
KR101840313B1 (ko) * 2011-02-14 2018-03-21 에스에프씨 주식회사 피리딘 유도체 화합물 및 이를 포함하는 유기전계발광소자
WO2012170931A2 (en) 2011-06-10 2012-12-13 Calcimedica, Inc. Compounds that modulate intracellular calcium
WO2013059677A1 (en) 2011-10-19 2013-04-25 Calcimedica, Inc. Compounds that modulate intracellular calcium
CA2863517C (en) * 2012-01-20 2019-11-05 Genosco Substituted pyrimidine compounds and their use as syk inhibitors
WO2014059333A1 (en) 2012-10-12 2014-04-17 Calcimedica, Inc. Compounds that modulate intracellular calcium
US10561676B2 (en) 2013-08-02 2020-02-18 Syntrix Biosystems Inc. Method for treating cancer using dual antagonists of CXCR1 and CXCR2
US8969365B2 (en) 2013-08-02 2015-03-03 Syntrix Biosystems, Inc. Thiopyrimidinecarboxamides as CXCR1/2 modulators
US10046002B2 (en) 2013-08-02 2018-08-14 Syntrix Biosystems Inc. Method for treating cancer using chemokine antagonists
TWI771269B (zh) 2015-02-27 2022-07-21 美商鈣系醫藥公司 胰腺炎治療
CA2995094A1 (en) 2015-08-07 2017-02-16 Calcimedica, Inc. Use of crac channel inhibitors for the treatment of stroke and traumatic brain injury
US11458126B2 (en) 2017-08-01 2022-10-04 Ptc Therapeutics, Inc. DHODH inhibitor for use in treating hematologic cancers
US11117893B2 (en) * 2018-09-24 2021-09-14 Union University Methods for preparation of substituted pyridines and related novel compounds
CA3172249A1 (en) 2020-03-20 2021-09-23 Calcimedica, Inc. Methods and compositions for treating acute lung injury and acute respiratory distress syndrome
JP7791898B2 (ja) 2020-11-13 2025-12-24 カルシメディカ，インク． Ｃｒａｃチャネル阻害剤の合成の改善

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ194747A (en) * 1979-08-29 1988-11-29 Schering Ag 9h-pyrido(3,4-b)indol-3-ylcarboxylic acid derivatives
SU859889A1 (ru) * 1980-01-17 1981-08-30 Читинский Медицинский Институт Способ количественного определени 1-метил-4-(N-метилпирролидил-1)- -карболин гидрохлорида
DE3240514A1 (de) * 1982-10-29 1984-05-03 Schering AG, 1000 Berlin und 4709 Bergkamen Ss-carboline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US5359078A (en) * 1989-05-19 1994-10-25 The United States Of America As Represented By The Department Of Health And Human Services Signal transduction inhibitor compounds
AU7570191A (en) * 1990-03-14 1991-10-10 Board Of Regents, The University Of Texas System Tripterygium wilfordii hook f extracts and components thereof for immunosuppression
EP0610744B1 (en) * 1993-02-09 1998-11-04 Bayer Corporation Sulfonamide aminomethylene derivatives as immunosuppressants
JPH07112918A (ja) * 1993-10-15 1995-05-02 Pola Chem Ind Inc 育毛剤及びこれを含有する頭髪用化粧料
DE19502753A1 (de) * 1995-01-23 1996-07-25 Schering Ag Neue 9H-Pyrido[3,4-b]indol-Derivate

Also Published As

Publication number Publication date
WO1998006719A1 (en) 1998-02-19
EP0923581A1 (en) 1999-06-23
DK0923581T3 (da) 2003-08-04
DE69722220D1 (de) 2003-06-26
DE69722220T2 (de) 2004-02-19
ES2194213T3 (es) 2003-11-16
JP2000516231A (ja) 2000-12-05
ATE240955T1 (de) 2003-06-15
US6093723A (en) 2000-07-25
CA2262796A1 (en) 1998-02-19
EP0923581B1 (en) 2003-05-21
CA2262796C (en) 2006-10-31

Similar Documents

Publication Publication Date Title
NL1007031A1 (nl) Hydroxyfenyltriazinen.
DE69708120D1 (de) Laser-absorbierende, lichtbleichbare zusammensetzungen
DK1086101T3 (da) Beta-carbolinforbindelser
DZ2261A1 (fr) Cyclo-alcane pyridines.
PT901474E (pt) Derivados de aril-pirimidina.
PT1023268E (pt) Isoquinolinas como inibidores de uroquinase
ITTO970975A0 (it) Composizioni organiche.
NL1011488A1 (nl) Hoofdtelefoon-microfoon-combinatie.
DE69709173D1 (de) Belastungswalzenanordnüng.
TR199901284A3 (tr) Ester bilesimleri.
ES1036598Y (es) Capazo-cuna.
PT1380585E (pt) Pirazolopiridinona como intermediario
ES1033200Y (es) Linterna - caramelo.
ES1034241Y (es) Nuevo implante endo-oseo.
ES1034273Y (es) Maleta-expositor transformable, perfeccionada.
ES1033500Y (es) Caja-expositor.
ES1035219Y (es) Chincheta-clip.
ES1034158Y (es) Arsonvalizador.
ES1033293Y (es) Quita esmaltes perfeccionado.
IT248282Y1 (it) Mandrino maschiatore.
ES1034580Y (es) Pieza deslizante -saltadora.
ITNA960027U1 (it) Eritropoietina biotinilata.
ES1044338Y (es) Desolladora manual.
ES1034834Y (es) Estanteria multifuncional perfeccionada.
ES1040387Y (es) Peonza perfeccionada de doble efecto.